Nitric-oxide (NO) and eNOS activity in vascular-research models using BPC-157
Although not the primary focus, it could be an added benefit
Because the bulk of published research investigating these two compounds in combination has used roughly equal proportions, and because there's no strong mechanistic reason to weight angiogenesis (BPC-157) over cell migration (TB-500) in tissue-repair research
S., Carreras, J., Panda, S., & Tsubota, K
Inconclusive data from a survey of one thousand patients cant negate an individuals claim that BPC-157 worked for them indeed, no one but the individual can validate or disprove such a claim
BPC-157: 0.5 mg daily, either as single dose or split 0.25 mg twice daily TB-500: 2-2.5 mg twice weekly (Monday/Thursday) totaling 4-5 mg per week Duration: 4-6 weeks loading phase, then 2-4 weeks maintenance Important: Use separate vials and syringes for each peptide